The short version
Just 3 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate, Scopolamine Hydrobromide
Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate, Scopolamine Hydrobromide · PHENOBARBITAL 16.2 mg/5mL; HYOSCYAMINE SULFATE .1037 mg/5mL; ATROPINE SULFATE .0194 mg/5mL; SCOPOLAMINE HYDROBROMIDE .0065 mg/5mL · Elixir · Oral · Ingenus Pharmaceuticals, LLC
NDC 50742-0665-04 · 118 mL in 1 BOTTLE · UNAPPROVED DRUG OTHER · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$75.00
Reported to Texas DSHS · 2026 annual filing · Ingenus Pharmaceuticals LLC
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate, Scopolamine Hydrobromide (Elixir)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Ingenus Pharmaceuticals, LLC | PHENOBARBITAL 16.2 mg/5mL; HYOSCYAMINE SULFATE .1037 mg/5mL; ATROPINE SULFATE .0194 mg/5mL; SCOPOLAMINE HYDROBROMIDE .0065 mg/5mL | Aug 26, 2026 | Sep 3, 2026 |
| VistaPharm, LLC | PHENOBARBITAL 16.2 mg/5mL; HYOSCYAMINE SULFATE .1037 mg/5mL; ATROPINE SULFATE .0194 mg/5mL; SCOPOLAMINE HYDROBROMIDE .0065 mg/5mL | Aug 26, 2026 | Sep 2, 2026 |
| Advanz Pharma (US) Corp. | PHENOBARBITAL 16.2 mg/5mL; HYOSCYAMINE SULFATE .1037 mg/5mL; ATROPINE SULFATE .0194 mg/5mL; SCOPOLAMINE HYDROBROMIDE .0065 mg/5mL | Aug 26, 2026 | Aug 28, 2026 |
| Advanz Pharma (US) Corp. | PHENOBARBITAL .0194 mg/5mL; HYOSCYAMINE SULFATE .1037 mg/5mL; ATROPINE SULFATE 16.2 mg/5mL; SCOPOLAMINE HYDROBROMIDE .0065 mg/5mL | Jul 22, 2026 | Aug 22, 2026 |
| Ingenus Pharmaceuticals, LLC | PHENOBARBITAL .0194 mg/5mL; HYOSCYAMINE SULFATE .1037 mg/5mL; ATROPINE SULFATE 16.2 mg/5mL; SCOPOLAMINE HYDROBROMIDE .0065 mg/5mL | Jul 22, 2026 | Aug 19, 2026 |
| VistaPharm, LLC | PHENOBARBITAL .0194 mg/5mL; HYOSCYAMINE SULFATE .1037 mg/5mL; ATROPINE SULFATE 16.2 mg/5mL; SCOPOLAMINE HYDROBROMIDE .0065 mg/5mL | Jul 22, 2026 | Aug 19, 2026 |
| Advanz Pharma (US) Corp. | ATROPINE SULFATE .0194 mg/5mL; HYOSCYAMINE SULFATE .1037 mg/5mL; PHENOBARBITAL 16.2 mg/5mL; SCOPOLAMINE HYDROBROMIDE .0065 mg/5mL | Jul 15, 2026 | Jul 19, 2026 |
| Ingenus Pharmaceuticals, LLC | ATROPINE SULFATE .0194 mg/5mL; HYOSCYAMINE SULFATE .1037 mg/5mL; PHENOBARBITAL 16.2 mg/5mL; SCOPOLAMINE HYDROBROMIDE .0065 mg/5mL | Jul 15, 2026 | Jul 19, 2026 |
| VistaPharm, LLC | ATROPINE SULFATE .0194 mg/5mL; HYOSCYAMINE SULFATE .1037 mg/5mL; PHENOBARBITAL 16.2 mg/5mL; SCOPOLAMINE HYDROBROMIDE .0065 mg/5mL | Jul 15, 2026 | Jul 15, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate, Scopolamine Hydrobromide — NDC 50742-0665-04," retrieved September 3, 2026, https://drugdashboards.com/drug/50742066504.
Free to cite with attribution — see how the data is put together.